Immunovant (NASDAQ:IMVT – Free Report) had its price objective decreased by Bank of America from $38.00 to $33.00 in a ...
Immunovant stock opened at $19.64 on Thursday. Immunovant has a 1 year low of $17.01 and a 1 year high of $34.47. The firm has a 50 day moving average price of $20.86 and a 200 day moving average ...
Argenx is a hold due to limited catalysts in 2025, a rich valuation and clinical risk around label expansion. Read more about ...
Stifel analyst Alex Thompson raised the firm’s price target on Immunovant (IMVT) to $61 from $58 and keeps a Buy rating on the shares following yesterday’s topline data from the Batoclimab Myasthtenia ...
We recently published a list of 10 Best Stocks to Buy According to Billionaire David Einhorn. In this article, we are going ...
OmniAb’s (OABI) stock tumbled roughly 25% this week after financial results for Q4 reflected a mix of revenue growth tempered by a downturn in ...
In this article, we will discuss the 10 Best Stocks to Buy According to Billionaire David Einhorn. David Einhorn is a highly ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
After hours: March 26 at 6:19:40 p.m. EDT Loading Chart for IMVT ...
After hours: March 21 at 5:54:19 PM EDT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results